NextEra Energy, Inc. (NEE) is now among the bigger bargains in its industry.
Within the last year the price ranged from $164.78 – 239.89 and there is a wide opportunity to get in. Its next earnings report will be released on Jan 24, 2020.

ZIOPHARM Oncology, Inc.(ZIOP)

move, based on 1 analyst offering 12 month price targets for Ziopharm Oncology in the last 3 months. The average price target is $6.50 with a high forecast of $6.50 and a low forecast of $6.50. The average price target represents a 24.76% increase from the last price of $5.21.

Analysts like Swayampakula Ramakanth from H.C. Wainwright believe that we could see stock price minimum $6.50.

Another prominent analyst, David Novak of Raymond James rates ZIOP as a Buy. The rating was made just 18 days ago.

ZIOPHARM Oncology, Inc.(ZIOP) Recent News Reports

On average 1.0 articles are written each week about ZIOP but this week 2 articles were written and they were 65% Bullish and 35% Bearish.

ZIOPHARM Oncology, Inc. Target Levels

The market experts are predicting that ZIOP is a Moderate Buy. Some other stocks to consider in this sector are:

EXC
D
DUK